Concurrent Investment Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Buy
31,126
+654
+2% +$29.8K 0.01% 755
2025
Q4
$1.35M Sell
30,472
-2,475
-8% -$107K 0.02% 710
2025
Q3
$1.39M Buy
32,947
+2,094
+7% +$84.4K 0.02% 559
2025
Q2
$1.13M Buy
30,853
+2,124
+7% +$78.9K 0.02% 565
2025
Q1
$1.09M Sell
28,729
-485
-2% -$18K 0.03% 528
2024
Q4
$1.11M Buy
29,214
+2,294
+9% +$91.7K 0.03% 463
2024
Q3
$1.1M Buy
26,920
+3,632
+16% +$137K 0.03% 435
2024
Q2
$798K Buy
23,288
+5,696
+32% +$179K 0.03% 486
2024
Q1
$557K Buy
17,592
+1,856
+12% +$56.4K 0.02% 518
2023
Q4
$482K Buy
+15,736
New +$505K 0.02% 505

Other funds holding OHI

Concurrent Investment Advisors's OHI Position: Q1 2026 in Review

Concurrent Investment Advisors increased its Omega Healthcare (OHI) stake by 2.1% in Q1 2026, buying an estimated $29.8K and bringing the position to 31,126 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #755.

Concurrent Investment Advisors first reported a position in OHI in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.39M in Q3 2025. 742 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Concurrent Investment Advisors held 31,126 shares of Omega Healthcare worth $1.36M as of Q1 2026.
  • Concurrent Investment Advisors bought 654 Omega Healthcare shares in Q1 2026, an estimated $29.8K.
  • Omega Healthcare made up 0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #755 holding.
  • Concurrent Investment Advisors first reported a position in Omega Healthcare in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's Omega Healthcare position peaked at $1.39M in Q3 2025.
  • 742 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.